Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 1
2007 1
2008 2
2010 1
2011 1
2012 3
2013 4
2014 10
2015 7
2016 4
2018 6
2019 4
2020 2
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
I. Introduction.
Miller PJ, Rosengren KS, Gutiérrez IT. Miller PJ, et al. Monogr Soc Res Child Dev. 2014 Mar;79(1):1-18. doi: 10.1111/mono.12076. Monogr Soc Res Child Dev. 2014. PMID: 24571454 No abstract available.
VII. Final thoughts.
Miller PJ, Rosengren KS. Miller PJ, et al. Monogr Soc Res Child Dev. 2014 Mar;79(1):113-24. doi: 10.1111/mono.12082. Monogr Soc Res Child Dev. 2014. PMID: 24571460 No abstract available.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Modified trauma assessment clinic: A rapid, scalable model.
Miller P, Hurley R, McCabe F, Turley L, O'Flanagan S, O'Shea K. Miller P, et al. J Orthop. 2022 Feb 9;30:59-61. doi: 10.1016/j.jor.2022.02.004. eCollection 2022 Mar-Apr. J Orthop. 2022. PMID: 35241889 Free PMC article.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Embracing Death: Mexican Parent and Child Perspectives on Death.
Gutiérrez IT, Menendez D, Jiang MJ, Hernandez IG, Miller P, Rosengren KS. Gutiérrez IT, et al. Among authors: miller p. Child Dev. 2020 Mar;91(2):e491-e511. doi: 10.1111/cdev.13263. Epub 2019 May 29. Child Dev. 2020. PMID: 31140591 Free PMC article.
52 results